Rick Zeifman

Clinical Psychologist | Assistant Professor @TheNewSchool

Researching trauma, mechanisms of change, and psychedelic therapy

[Rick Zeifman @RickZeifman]

The Psychedelic-Assisted Therapy (PATH) Lab at The New School for Social Research is now live:
https://t.co/W6zEwdyXE5

We study the benefits and risks of psychedelic-assisted therapy, with a focus on mechanisms of change, complex presentations, and real-world effectiveness.

[Rick Zeifman @RickZeifman]

Looking forward to sharing our research over the coming years. For those interested in joining the lab, collaborating, or contributing to our work, please feel free to reach out.

[Rick Zeifman @RickZeifman]

The Psychedelic-Assisted Therapy (PATH) Lab at The New School for Social Research is now live:
https://t.co/W6zEwdyXE5

We study the benefits and risks of psychedelic-assisted therapy, with a focus on mechanisms of change, complex presentations, and real-world effectiveness.

[Rick Zeifman @RickZeifman]

Thanks to @CooperTretterand Silver Liftin for their work on the site, and to Diego Miró-Rivera for generously creating our logo and sharing his photography!

[Rick Zeifman @RickZeifman]

@RCarhartHarris I've definitely heard of cases of significantly delayed onset because of this in clinical contexts

[Rick Zeifman @RickZeifman]

@RCarhartHarris @BWe1ss Looks like another (small) data point not supportive of expectancy effects https://t.co/37otq1CQlI

Interesting to see if this scales as the population receiving PT widens

I'm also interested in expectation around PT effects being passive (automatic) vs. active (a process/work)

[Rick Zeifman @RickZeifman]

@RCarhartHarris Thanks, Robin (@RCarhartHarris)! Great to get to work with you on this!

[Rick Zeifman @RickZeifman]

Great to see this pre-print (led by Gabby Agin-Liebes) out in the world!

Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder https://t.co/lyt2xUtxk3 via @OSFramework

[Rick Zeifman @RickZeifman]

Nice to see this paper (led by Gabby Agin-Liebes) published on the effects of MDMA-assisted therapy for posttraumatic stress disorder on self-compassion and the role of self-compassion in mediating treatment outcomes

https://t.co/Wm7IYBZOiv

[Rick Zeifman @RickZeifman]

Great to see our paper led by Brennan published!

It reviews a wide breadth of research and carefully considers the therapeutic potential, risks, and key considerations surrounding psychedelic therapy for personality disorders. The evidence base is limited: more research needed.

[Robin Carhart-Harris @RCarhartHarris]

Big up Brennan and co! Exploring Serotonergic Psychedelics as a Treatment for Personality Disorders https://t.co/OjPvvKsatK

[Robin Carhart-Harris @RCarhartHarris]

Extremely excited about this stellar work and new measure from @RickZeifman and co. The 'REB-Q' has a great future: "From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)." https://t.co/68pRJ5RbMn

[Rick Zeifman @RickZeifman]

Excited about our study examining psilocybin-assisted massed cognitive processing therapy for posttraumatic stress disorder
with @shakilameshkat @KatieSPsych @CandiceMonson @venkatbhat @Dr_VenkatBhat @rakeshjetly

Protocol paper now available at @PLOSONE https://t.co/btN82gjEo1

[Rick Zeifman @RickZeifman]

Excited to share this paper led by Broc Pagni

Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial | American Journal of Psychiatry https://t.co/1z5khFEPHI

[Rick Zeifman @RickZeifman]

Happy to share our new paper on suicidal ideation in the context of PTSD

"Which PTSD clusters and symptoms are central to reducing suicidal ideation? A network and cross-lagged analysis among individuals receiving cognitive processing therapy"
https://t.co/sQCg7fnNr1

[Rick Zeifman @RickZeifman]

Excited to get to share this pre-print/findings!

[Robin Carhart-Harris @RCarhartHarris]

This is big

[Rick Zeifman @RickZeifman]

@hannahmdouglass Congratulations @hannahmdouglass !!

[Rick Zeifman @RickZeifman]

I'm grateful to have received this award from @nyulangone @NYULH_postdocs

[NYU Langone Postdoctoral Affairs @NYULH_postdocs]

🎉Congratulations to the 2024 Outstanding Postdocs and Outstanding Mentor! With this award, we celebrate their contributions and the invaluable roles they play in our institution’s research excellence. @nyugrossman @nyulangone

[Rick Zeifman @RickZeifman]

Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer

Grateful to collaborate on this paper led by @PPetridisMD

https://t.co/xWmEsoPosX

[Petros Petridis @PPetridisMD]

Psilocybin-assisted therapy provides more than just relief from anxiety and depression in patients with cancer.

Our analysis in @NatMentHealth reveals improvements in obsession-compulsion, hostility, somatization, & more.

Read the full paper here: https://t.co/1JL6G4Qi9O

[HCPLive @HCPLiveNews]

Lastly, Alexandra Gordon of @nyulangone describes the promising clinical effect of psychedelics for the treatment of personality disorder. #APAAM24

[Rick Zeifman @RickZeifman]

@trpwolff Interesting for sure. I wasn't involved in the primary outcomes paper where depression was the primary outcome but given the very small sample and psychotherapeutic framing of the treatment it seems understandable. Looking forward to hearing about what you found in yours!

[Rick Zeifman @RickZeifman]

@trpwolff It wasn't a focus unfortunately and MEQ didn't correlate with the depression outcome. A few ongoing studies with the APEQ, so will look forward to testing out link between acute states and changes in traits. Will be sure to reference and will try to invite you to explore with us!